Chandraprabha Vati
Chandraprabha Vati is a classical Ayurvedic vati, a herbal tablet or pill. Listed in the Ayurvedic Formulary of India (AFI) Part I. Sharangdhara Samhita, Madhyama Khanda, Chapter 7 (Vatika Adhikara). Also described in Bhaishajya Ratnavali (Prameha Rogadhikara) and Chakradatta. The Ayurvedic Formulary of India (Part I, entry 12:10) lists 37 ingredients, beginning with Candraprabha, Vaca, Musta and Bhunimba.
| Also known as | Chandraprabha Vati, ChandraprabhaVati |
|---|---|
| Pharmacopoeia status | Listed in the Ayurvedic Formulary of India (AFI) Part I. Standardized according to the Ayurvedic Pharmacopoeia of India by the Pharmacopoeia Commission for Indian Medicine & Homoeopathy (PCIM&H). One of the most widely prescribed classical formulations in Indian Ayurvedic practice. |
Composition
As given in the Ayurvedic Formulary of India, Part I, entry 12:10 (CANDRAPRABHA VATI), which cites Sarngadharasamhita, Madhyamakhanda, Adhyaya 7; 40-44.. Names, parts and quantities are transcribed as printed and checked row by row against the book. Manufacturers' versions of a classical formulation can differ from the formulary.
| # | Ingredient | Part | Quantity |
|---|---|---|---|
| 1 | Candraprabha (karpura) | Sub. Ext. | 3 g |
| 2 | Vaca * | rhizome | 3 g |
| 3 | Musta * | rhizome | 3 g |
| 4 | Bhunimba (kiratatikta) * | whole plant | 3 g |
| 5 | Amrta (guduci) * | stem | 3 g |
| 6 | Daruka (devadaru) | heart wood | 3 g |
| 7 | Haridra * | 3 g | |
| 8 | Ativisa * | 3 g | |
| 9 | Darvi (daruharidra) | stem | 3 g |
| 10 | Pippalimula (pippali) | root | 3 g |
| 11 | Citraka * | root | 3 g |
| 12 | Dhanyaka * | fruit | 3 g |
| 13 | Haritaki * | pericarp | 3 g |
| 14 | Bibhitaka * | pericarp | 3 g |
| 15 | Amalaki * | pericarp | 3 g |
| 16 | Cavya * | stem | 3 g |
| 17 | Vidanga * | fruit | 3 g |
| 18 | Gajapippali | fruit | 3 g |
| 19 | Sunthi * | rhizome | 3 g |
| 20 | Marica * | fruit | 3 g |
| 21 | Pippali * | fruit | 3 g |
| 22 | Maksika dhatu bhasma (maksika) * | 3 g | |
| 23 | Yava ksara (yava) * | whole plant | 3 g |
| 24 | Sarji ksara (svarji ksara) | 3 g | |
| 25 | Saindhava lavana * | 3 g | |
| 26 | Sauvarcala lavana * | 3 g | |
| 27 | Vida lavana | 3 g | |
| 28 | Trivrt | root | 12 g |
| 29 | Danti | root | 12 g |
| 30 | Patraka (tejapatra) | leaf | 12 g |
| 31 | Tvak | stem bark | 12 g |
| 32 | Ela (suksmaila) * | seed | 12 g |
| 33 | Vamsarocana (vamsa) * | 12 g | |
| 34 | Hata loha bhasma (lauha) * | 24 g | |
| 35 | Sita | 48 g | |
| 36 | Silajatu | 96 g | |
| 37 | Guggulu | exudate | 96 g |
* The scanned text was damaged at this row and the name was read from the entry's own Sanskrit verse.
The evidence at a glance
5papers on this site for this drug, published 2013 to 2024, 4 with a DOI.
- 5Laboratory and animal studies
A count is not a conclusion and a tier is a study design, not a verdict. Everything listed here is laboratory or animal work, which does not show an effect in people.true See the research index for how papers are tiered.
Names and identification
| Language | Name |
|---|---|
| English | Chandraprabha Vati |
Where is it described in the classical texts?
Sharangdhara Samhita, Madhyama Khanda, Chapter 7 (Vatika Adhikara). Also described in Bhaishajya Ratnavali (Prameha Rogadhikara) and Chakradatta. One of the most referenced polyherbal formulations across multiple classical Ayurvedic texts.
How does it work?
- Multi-target metabolic modulation: Network pharmacology reveals 328 bioactives acting on multiple targets for obesity, hyperglycemia, and dyslipidemia simultaneously.
- Anti-inflammatory activity: An in vitro study on bladder cells reported anti-inflammatory activity, described in the source notes as reduced IL-6 and TNF-alpha secretion.
- Anti-hyperglycemic action: Modulates glucose metabolism and insulin sensitivity pathways, attenuating lipid profile alterations.
- Diuretic effects: Traditionally described as promoting urine flow through combined action of Gokshura, Shilajit, and other ingredients.
Which traditional uses are supported by research?
These summaries come from the source notes, which do not name the studies behind them.
- Urinary tract disorders and cystitis: traditionally used for urinary tract disorders and cystitis. An in vitro study on bladder cells reported anti-inflammatory activity.
- Prameha/Diabetes: traditionally used for prameha. Animal studies have reported antidiabetic activity.
- Metabolic syndrome: traditionally used for metabolic syndrome.
- Male reproductive health and oligospermia: traditionally used for male reproductive health and oligospermia. A clinical study reported improvement in sperm count and motility.
What do recent studies show?
No study for this section could be traced to a published paper. Classical formulations are researched largely in journals that PubMed does not index, so an absence here reflects the reach of the index rather than the state of the evidence.
Recent safety updates
- No major side effects or serious adverse reactions reported at recommended therapeutic doses (250-500 mg twice daily). Over-dosage may cause mild burning sensation in the abdomen.
- Contains Loha Bhasma (iron calx) and other mineral bhasmas; should be avoided in conditions of iron overload and not taken concurrently with certain modern medicines without medical supervision.
- Contraindicated in pregnancy. Extra precautions advised for children and elderly. Patients with renal impairment should consult a physician due to mineral content.
Dosage forms and preparation
Dosage Forms: Vati (tablet/pill), Modern compressed tablet, Capsule (modern)
Standard Dosage: 250-500 mg twice daily with warm water or milk. The Ayurvedic Formulary of India attributes this formula to Sarngadharasamhita, Madhyamakhanda, Adhyaya 7; 40-44.
Optimal Timing: After meals, twice daily, or as directed. Often taken with meals for urogenital conditions.
Storage: Store in airtight containers in a cool, dry place. Protect from moisture. Temperature not exceeding 30°C.
Marker Compounds: Fulvic acid (from Shilajatu), Z-Guggulsterone, E-Guggulsterone, Piperine, Gallic acid, Embelin (from Vidanga)
Vehicle (Anupana): Warm water, milk, or as directed based on condition
Synergistic Combinations
- Gokshuradi Guggulu
- Punarnavadi Kwath
- Shilapravang Vati
- Varunadi Kwath
What manufacturers publish about this preparation
Disclosure first. This site is published by Age Ayurveda, which sells Ayurvedic products, though not this preparation. Every cell states what that company's own product page carried when it was read, not our judgement of it. There is no score, no rank and no winner here, and the table is in alphabetical order for that reason.
The formulary entry above fixes the ingredients and the quantity of each. Whether you can check a particular product against it depends on what its manufacturer publishes. Of the 4 companies surveyed that sell a product under this name, this is what their pages carried when they were read on 8 October 2026.
| Company | What its product page publishes |
|---|---|
| Baidyanath | Neither an ingredient list nor quantities |
| Maharishi Ayurveda | Neither an ingredient list nor quantities |
| Patanjali Ayurved | An ingredient list, without quantities |
| The Arya Vaidya Pharmacy, Coimbatore | Neither an ingredient list nor quantities |
This measures what each company publishes, not the quality of anything it makes. A company that publishes nothing here may make an excellent preparation, and the label in the box is a separate, regulated surface that is not what was read. What disclosure changes is whether a reader, a pharmacist or an answer engine can check a product against the formulary entry it claims.
Method, the full counts across every company surveyed, and what this measurement got wrong the first time: which manufacturers publish what is in the bottle. The URL of every page read is recorded in brand-disclosure.json. If a row here is wrong, including where the correction favours a company other than ours, tell us and we will fix it and say that we did. How the same companies' stated doses compare with the formulary dose, preparation by preparation: Ayurvedic company doses against the Ayurvedic Formulary of India.
Published research
Literature indexed in PubMed that concerns this subject, grouped by study type. A paper appearing here is a record of what has been published, not evidence that the subject works, and laboratory or animal results do not transfer to people. Study titles link to PubMed so you can read the source rather than take our word.
Laboratory and animal studies5
- 2024. Network pharmacology analysis of Chandraprabha Vati: A new hope for the treatment of Metabolic SyndromeJournal of Ayurveda and integrative medicine. PMID 38821011 · doi:10.1016/j.jaim.2024.100902
- 2016. Antidiabetic activity of Chandraprabha vati - A classical Ayurvedic formulationJournal of Ayurveda and integrative medicine. PMID 27665674 · doi:10.1016/j.jaim.2016.08.010
- 2013. Modulatory effect of Chandraprabha Vati on antimicrobial peptides and inflammatory markers in kidneys of mice with urinary tract infectionIranian journal of kidney diseases. PMID 24072152
- 2020. Herbalome of Chandraprabha vati, a polyherbal formulation of Ayurveda prevents fibrillation of lysozyme by stabilizing aggregation-prone intermediate stateInternational journal of biological macromolecules. PMID 31945445 · doi:10.1016/j.ijbiomac.2020.01.121
- 2018. Establishment of quality function deployment with special reference to good manufacturing practice of Chandraprabha VatiAyu. PMID 30595632 · doi:10.4103/ayu.AYU_44_18
Reviewed by Dr. Awadesh Pratap Singh, BAMS, on 11 October 2026. What that review covered.
Consult a qualified vaidya before acting on anything here. Ayurvedic practice is prescribed to a person, not to a condition: the same dravya is given, withheld or substituted depending on your constitution, your agni, the season and what else you are already taking. A page cannot know any of that. Self-prescribing from a reference is how the wrong preparation, the wrong dose or the wrong anupana gets used.
Educational reference only. Nothing on this page is medical advice, a diagnosis, or a recommendation to take anything. Traditional uses and research findings are reported as published, not as claims about what any product does. If you take prescribed medication, raise any interaction with the prescriber rather than acting on a page. See our editorial standards.